DK144989A - Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse - Google Patents

Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse

Info

Publication number
DK144989A
DK144989A DK144989A DK144989A DK144989A DK 144989 A DK144989 A DK 144989A DK 144989 A DK144989 A DK 144989A DK 144989 A DK144989 A DK 144989A DK 144989 A DK144989 A DK 144989A
Authority
DK
Denmark
Prior art keywords
pyroles
disubstituted
intermediates
procedures
preparation
Prior art date
Application number
DK144989A
Other languages
English (en)
Other versions
DK144989D0 (da
Inventor
Walter Huebsch
Rolf Angerbauer
Peter Fey
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3809860A external-priority patent/DE3809860A1/de
Priority claimed from IT8822158A external-priority patent/IT8822158A0/it
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK144989D0 publication Critical patent/DK144989D0/da
Publication of DK144989A publication Critical patent/DK144989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK144989A 1988-03-24 1989-03-22 Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse DK144989A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3809860A DE3809860A1 (de) 1988-03-24 1988-03-24 Disubstituierte pyrrole
IT8822158A IT8822158A0 (it) 1988-10-03 1988-10-03 Pirroli disostituiti.

Publications (2)

Publication Number Publication Date
DK144989D0 DK144989D0 (da) 1989-03-22
DK144989A true DK144989A (da) 1989-09-25

Family

ID=25866308

Family Applications (1)

Application Number Title Priority Date Filing Date
DK144989A DK144989A (da) 1988-03-24 1989-03-22 Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse

Country Status (13)

Country Link
US (1) US4937255A (da)
EP (1) EP0334147A1 (da)
JP (1) JPH01283263A (da)
KR (1) KR890014472A (da)
CN (1) CN1036565A (da)
AU (1) AU3160589A (da)
DK (1) DK144989A (da)
FI (1) FI891365A7 (da)
HU (1) HUT52047A (da)
IL (1) IL89664A0 (da)
NO (1) NO890988L (da)
NZ (1) NZ228440A (da)
PT (1) PT90082A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243279A1 (de) * 1992-12-21 1994-06-23 Bayer Ag Substituierte Triole
US5890644A (en) * 1996-01-26 1999-04-06 Micron Technology, Inc. Apparatus and method of clamping semiconductor devices using sliding finger supports
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
WO2017029684A1 (en) * 2015-08-17 2017-02-23 University Of Mysore 2,3,5 trisubstituted pyrrole derivatives as topoisomerase inhibitors and therapeutic uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598775B2 (en) * 1985-10-25 1990-07-05 Sandoz Ag Heterocyclic analogs of mevalonolactone
DE3539668A1 (de) * 1985-11-08 1987-05-21 Draegerwerk Ag Lungengesteuertes membranventil fuer atemschutzmasken

Also Published As

Publication number Publication date
NO890988D0 (no) 1989-03-08
AU3160589A (en) 1989-09-28
PT90082A (pt) 1989-11-10
NZ228440A (en) 1991-02-26
JPH01283263A (ja) 1989-11-14
US4937255A (en) 1990-06-26
HUT52047A (en) 1990-06-28
CN1036565A (zh) 1989-10-25
FI891365A7 (fi) 1989-09-25
FI891365A0 (fi) 1989-03-22
IL89664A0 (en) 1989-09-28
EP0334147A1 (de) 1989-09-27
KR890014472A (ko) 1989-10-23
DK144989D0 (da) 1989-03-22
NO890988L (no) 1989-09-25

Similar Documents

Publication Publication Date Title
DK345488A (da) Azolylmethyl-cyclopropyl-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189D0 (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK328585A (da) Modificerede succinimider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK39885D0 (da) Paaviselige molekyler samt fremgangsmaade til deres fremstilling og anvendelse
NO873640L (no) Nye cefemforbindelser og fremgangsmaate til deres fremstilling.
DK536488A (da) Alkadienderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt laegemidler deraf
DK494589A (da) Substituerede 1,3,5-triazintrioner og deres anvendelse samt mellemprodukter til deres fremstilling
DK88989D0 (da) Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK104589D0 (da) Substituerede acrylsyreestere, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK358389D0 (da) 4-halogen-5-nitrothiazol-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK178589D0 (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK144989D0 (da) Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK639888D0 (da) 3-aminopyrazolin-5-oner, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK79389D0 (da) Thiorhodaminer samt fremgangsmaade og mellemprodukter til deres fremstilling
DK540887D0 (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK548086D0 (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089D0 (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK355389A (da) Hydroxyalkynyl-azolylderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK630788A (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
DK355289D0 (da) 2,2-dihalogencyclopropyl-hydroxy-ethyltriazoler, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK378989D0 (da) Halogenvinylazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK264788A (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse